Product Images Brimonidine Tartrate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Brimonidine Tartrate NDC 70069-232 by Somerset Therapeutics, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is the information of an ophthalmic solution containing Brimonidine Tartrate 0.2% as its active ingredient. It also contains Benzalkonium chloride (0.005%) as a preservative. The solution is intended for use in the eyes only and is manufactured by Soneret eapesis LG. Other details include the manufacturer's address, company name, and a non-rash area of 14x10 mm.*
This is a description of Brimonidine Tartrate Ophthalmic Solution manufactured by Somerset Therapeutics in India. It contains active ingredient Brimonidine tartrate 0.2% and preservative Benzalkonium chloride (0.005%). The inactives include Citric Acid, Pown, Alcohol, Sodium Chloride; Sodium Citrate, Water for Injection. This solution is recommended for use in the eyes only, with one drop three times daily in the affected eye. The usual dosage is approximately eight hours apart. It is important not to touch dropper tip to any surface to avoid contamination. It should be stored between 15° - 25°C (59° - 77°F) and kept out of reach of children.*
This is a prescription eye medication with active ingredient Brimonidine Tartrate 0.2%. The preservative used in the solution is Benzakonium Chloride (0.005%). The recommended storage temperature is between 15°C to 25°C. It comes in a 10mL bottle and is for use in the eyes only. It is manufactured by Saeret Therapeutics. Further details include the NDC code, manufacturer's address, and a caution code.*
This is a description of Brimonidine Tartrate Ophthalmic Solution, manufactured by Somerset Therapeutics LLC in India. The product comes in a 10 mL bottle and is intended for use in the eyes only. It contains 0.2% Brimonidine tartrate as an active ingredient, along with Benzalkonium chloride as a preservative, and other inactive ingredients. The recommended dosage is one drop in the affected eye(s) three times a day, with approximately 8 hours apart. The dropper tip should not be touched to any surfaces to avoid contamination, and the product should be stored between 15° - 25°C (59° - TT°F), away from children.*
Brimonidine Tartrate Ophthalmic Solution is a prescription drug. It contains 0.2% Brimonidine tartrate as the active ingredient and 0.005% Benzalkonium chloride as a preservative. It is only for use in the eyes and should be stored within the temperature range of 15°-25°C (59°-77°F). It comes in a 15mL bottle and has an NDC number of 70069-233-01. The manufacturer is Somerset Therapeutics, and it is manufactured in Hallywood, FL3302.*
This is a prescription ophthalmic solution containing 0.2% brimonidine tartrate, manufactured by Somerset Therapeutics LLC in India. The solution comes in a 15 mL bottle for use in the eyes only. The usual dosage instructions advise to instill one drop three times daily in the affected eye(s), approximately 8 hours apart. It contains benzalkonium chloride (0.005%) as a preservative and other inactive ingredients: citric acid, polyvinyl alcohol, sodium chloride, sodium citrate, water for injection. The pH may be adjusted with Hydrochloric Acid and/or Sodium Hydroxide. The product must be stored between 15° - 25°C (59° - 77°F) and kept out of reach of children. The package contains customer care information and a warning not to touch the dropper's tip to any surface, as this may contaminate the solution.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.